Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis
Completed
Taro Pharmaceuticals USA
Phase 4
2015-01-23
The objective of this study is to evaluate the potential of Topicort® (desoximetasone)
Topical Spray, 0.25% to suppress hypothalmic pituitary adrenal axis function. The secondary
objectives are to evaluate the efficacy parameters, pharmacokinetics and adverse event
profile.
Topical Psoriasis Study for Patients Receiving Biologic Therapy
Completed
Taro Pharmaceuticals USA
Phase 4
2016-03-01
A two-phase, single center, study of 20 subjects to assess 4 weeks of add-on therapy of
Topicort® BID and 12 weeks BID on two consecutive days a week to patients with ≤5% BSA who
are receiving biologic therapy for at least 24 weeks
Topical Psoriasis Study for Patients Receiving Biologic Therapy
Completed
Psoriasis Treatment Center of Central New Jersey
Phase 4
2016-03-01
A two-phase, single center, study of 20 subjects to assess 4 weeks of add-on therapy of
Topicort® BID and 12 weeks BID on two consecutive days a week to patients with ≤5% BSA who
are receiving biologic therapy for at least 24 weeks
Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
Completed
Taro Pharmaceuticals USA
Phase 4
2016-09-01
A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily
BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
